Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHGDH | O43175 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.56 |
| ▸ | HPGD | P15428 | 8/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19066920 | 0.87 | PHGDH (1.00) | PHGDHMAPK1ALDH1A1HPGDKMT2A | |
| SCHEMBL19066922 | 0.86 | PHGDH (0.76) | PHGDHMAPK1ALDH1A1HPGDKMT2A | |
| SCHEMBL19066918 | 0.70 | ADORA2A (0.39) | PHGDHMAPK1ALDH1A1HPGDKMT2A | |
| SCHEMBL27383298 | 0.66 | NPC1 (0.56) | ALDH1A1KMT2AMEN1KDM4ETSHR | |
| SCHEMBL8288738 | 0.65 | HPGD (0.74) | PHGDHMAPK1ALDH1A1HPGDKMT2A | |
| SCHEMBL31072940 | 0.65 | NPC1 (0.55) | ALDH1A1KMT2AMEN1KDM4ETSHR | |
| SCHEMBL28793821 | 0.64 | RAB9A (0.62) | ALDH1A1HPGDKMT2AMEN1KDM4E | |
| SCHEMBL7079634 | 0.64 | RAB9A (0.64) | MAPK1ALDH1A1HPGDKMT2AMEN1 | |
| SCHEMBL1620208 | 0.63 | HPGD (0.53) | MAPK1ALDH1A1HPGDKMT2AMEN1 | |
| SCHEMBL2644226 | 0.62 | APOBEC3G (0.72) | MAPK1ALDH1A1HPGDKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190010144-A1 | SMALL MOLECULE INHIBITOR OF 3-PHOSPHOGLYCERATE DEHYDROGENASE AND USES THEREOF | CORNELL UNIVERSITY | 2019-01-10 | — | — | US | disclosed |
| WO-2017117532-A1 | SMALL MOLECULE INHIBITOR OF 3-PHOSPHOGLYCERATE DEHYDROGENASE AND USES THEREOF | CANTLEY LEWIS C (US) | 2017-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190010144-A1 | SMALL MOLECULE INHIBITOR OF 3-PHOSPHOGLYCERATE DEHYDROGENASE AND USES THEREOF | PHGDH, G6PD, PGD | PHGDH 1/4885MAPK1 2895/4885ALDH1A1 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.